PVIVAX

Knowledge sharing for relapsing malaria

Search

  • English
  • Español
  • Français
  • P. vivax
    • Malaria and P. vivax malaria
    • Symptoms & severity
    • Morbidity and mortality
    • Populations at risk
      • Pregnant women and children
      • Migratory populations
    • Role in malaria elimination
    • Lifecycle
    • Relapses
    • Vectors
  • Diagnosis & treatment
    • Diagnostic methods
      • Microscopy
      • Rapid diagnostic tests
      • Molecular methods & serology
    • Diagnosing severe vivax malaria
    • Treatment
      • Radical cure
      • Blood stage treatment
      • Liver stage treatment
    • G6PD Deficiency
      • G6PD Global Prevalence
      • G6PD diagnostics
      • Types of G6PD clinical diagnostic tests
  • Regions & countries
    • Africa
    • Eastern Mediterranean
    • South East Asia
    • The Americas
    • Western Pacific
  • In the field
  • Tools
  • Resources
  • News & events
  • About us
Photo: Hadynyah/istock

About the P. vivax information hub 

Find out more
Photo: Hadynyah/istock
Photo: Maud Majeres Lugand / MMV

Advancing the introduction and scale-up of G6PD diagnostics

Find out more
Photo: Maud Majeres Lugand / MMV
Photo: BartCo/istock

First single-dose medicine to prevent the relapse of P. vivax malaria 

Find out more
Photo: BartCo/istock

Featured resources

24 Jul 2019

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial

Primaquine prevents Plasmodium vivax malaria relapses, but adherence to the standard 14-day regimen is poor. We aimed to assess the efficacy of a shorter course (7 days) of primaquine for radical cure of vivax malaria.

Lancet
Peer-reviewed article
15 Apr 2019

2018 in review: five hot topics in tropical medicine

Tafenoquine for Plasmodium vivax malaria is heralded among the five new developments in the field of tropical medicine in 2018. 

Tropical Diseases, Travel Medicine and Vaccines
Peer-reviewed article
01 Jul 2015

Control and elimination of Plasmodium vivax malaria – A technical brief

This technical brief developed by the World Health Organisation reviews the biological characteristics, geographical distribution and worldwide burden of P. vivax malaria. 

World Health Organisation
Strategy
15 Sep 2015

Implementation of G6PD testing and radical cure in P. vivax endemic countries: considerations

This technical brief features discussions on translating guidelines into policy and strategy in programmes for the control and elimination of Plasmodium vivax malaria.

World Health Organisation
Guidance Document
1

News

Photo: Marco Corsi/Sigma Tau

New maps could show how to beat malaria

24 Jun 2019

PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria

23 Apr 2019

New opportunities to prevent P. vivax malaria relapse

25 Feb 2019

A high risk of P. vivax after P. falciparum infection

13 Feb 2019
View news and events
1

Publications

09 Aug 2019

Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report.

BMC Infect Dis
Peer-reviewed article
01 Aug 2019

Tuberculosis and malaria walk side by side in the Brazilian Amazon: an ecological approach.

Trop Med Int Health
Peer-reviewed article
01 Aug 2019

Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cure.

Int Ophthalmol
Peer-reviewed article
01 Aug 2019

The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.

BMC Med
Peer-reviewed article
View all publications

Get in touch

Contact us.

Submit information

Subscribe

Links

Privacy policy

Disclaimer

A Remora website by Manta Ray Media